Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2497094rdf:typepubmed:Citationlld:pubmed
pubmed-article:2497094lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0522537lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0206243lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0054692lld:lifeskim
pubmed-article:2497094lifeskim:mentionsumls-concept:C0598452lld:lifeskim
pubmed-article:2497094pubmed:issue5lld:pubmed
pubmed-article:2497094pubmed:dateCreated1989-6-19lld:pubmed
pubmed-article:2497094pubmed:abstractTextThe effects of two new perfluorochemical emulsions based on F-66E and PFOB which carry, in combination with carbogen, more oxygen than Fluosol-DA 20% were investigated on a human tumor xenograft (HRT18). Tumor bearing mice were pretreated with 15 ml/kg of F-66E emulsion (50 w/v%) or PFOB (100 w/v%) emulsion in the presence of carbogen for 1 hr prior to and during irradiation. F-66E emulsion was non toxic in vitro. In vivo, the dose modifying factor was 1.8 for mice pretreated with carbogen and F-66E emulsion whereas it was 1.6 for carbogen-breathing mice. Results with PFOB emulsion were similar to those obtained with F-66E emulsion. The effect of F-66E emulsion was studied using a fractionated radiation treatment: 12 Gy were delivered in 6 fractions of 2 Gy with an interval of 8 hrs between fractions. A single dose of F-66E emulsion was injected before the first irradiation. Surviving fractions were 0.35 for air-breathing mice, 0.091 for carbogen-breathing mice and 0.099 for carbogen-breathing mice pretreated with F-66E emulsion. These results showed that carbogen alone or carbogen plus F-66E or PFOB emulsion were very efficient even with low doses of radiation.lld:pubmed
pubmed-article:2497094pubmed:languageenglld:pubmed
pubmed-article:2497094pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:citationSubsetIMlld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2497094pubmed:statusMEDLINElld:pubmed
pubmed-article:2497094pubmed:monthMaylld:pubmed
pubmed-article:2497094pubmed:issn0360-3016lld:pubmed
pubmed-article:2497094pubmed:authorpubmed-author:ThomasCClld:pubmed
pubmed-article:2497094pubmed:authorpubmed-author:MalaiseE PEPlld:pubmed
pubmed-article:2497094pubmed:authorpubmed-author:GuichardMMlld:pubmed
pubmed-article:2497094pubmed:authorpubmed-author:LartigauEElld:pubmed
pubmed-article:2497094pubmed:issnTypePrintlld:pubmed
pubmed-article:2497094pubmed:volume16lld:pubmed
pubmed-article:2497094pubmed:ownerNLMlld:pubmed
pubmed-article:2497094pubmed:authorsCompleteYlld:pubmed
pubmed-article:2497094pubmed:pagination1157-60lld:pubmed
pubmed-article:2497094pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:meshHeadingpubmed-meshheading:2497094-...lld:pubmed
pubmed-article:2497094pubmed:year1989lld:pubmed
pubmed-article:2497094pubmed:articleTitleNew high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.lld:pubmed
pubmed-article:2497094pubmed:affiliationLaboratoire de Radiobiologie Cellulaire (Unité Inserm 247), Institut Gustave-Roussy, Villejuif, France.lld:pubmed
pubmed-article:2497094pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2497094pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2497094lld:pubmed